Latest / The Well-Built Life / Beyond Immortality: The New Frontier of Healthspan
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:06Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple practical habits that help you feel stronger, healthier,
- 0:17Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:21Speaker 1: and let's dive in. All right, Thomas, let's kick off
- 0:24Speaker 1: our discussion with something a bit different. Have you had
- 0:27Speaker 1: a chance to delve into the myth of Tithonus? It's
- 0:30Speaker 1: quite fascinating how it parallels our current discourse on longevity.
- 0:34Speaker 2: Absolutely, Rachel. The Tithonus myth is a perfect entry point.
- 0:39Speaker 2: In the story, he and goddess Eos fall in love,
- 0:42Speaker 2: and Tithonus requests immortality from Helios. However, he neglects to
- 0:47Speaker 2: ask for eternal youth. As a result, he endures a
- 0:50Speaker 2: life plagued by perpetual aging and eventual misery. It's a
- 0:53Speaker 2: stark reminder that simply extending life without considering the quality
- 0:58Speaker 2: of life can be detrimental.
- 1:00Speaker 1: Exactly. And this myth really resonates with our current understanding
- 1:03Speaker 1: of longevity, where the focus is shifting from just extending
- 1:06Speaker 1: the number of years to enhancing the quality of those years.
- 1:09Speaker 1: We are now looking at healthspan, how many years we
- 1:12Speaker 1: feel and function as if we were younger.
- 1:15Speaker 2: Right. In the 21st century, to raise a renewed interest
- 1:18Speaker 2: in longevity and healthspan, driven by medical advancements in research,
- 1:23Speaker 2: organizations like the Sense Research Foundation established are doing pioneering
- 1:27Speaker 2: work in understanding the biological mechanisms of aging and developing
- 1:31Speaker 2: interventions to prolong healthy life. Can you talk a bit
- 1:34Speaker 2: more about the mechanisms involved, Rachel?
- 1:36Speaker 1: Certainly. Key mechanisms include things like telomere length, autophagy, and
- 1:41Speaker 1: cellular senescence. These are all important biological processes. For instance,
- 1:48Speaker 1: telomeres are like caps on our chromosomes. As they shorten,
- 1:52Speaker 1: we age, strategies to maintain or lengthen these telomeres, could
- 1:56Speaker 1: potentially slow down the aging process.
- 1:58Speaker 2: That's interesting. And to raise the metabolic and hormonal factors,
- 2:03Speaker 2: insulin resistance and mitochondrial function play significant roles. These mechanisms
- 2:08Speaker 2: are integral to understanding how we age and develop diseases.
- 2:12Speaker 2: For example, insulin resistance is often associated with type 2 diabetes,
- 2:17Speaker 2: which can accelerate the aging process.
- 2:20Speaker 1: Exactly. And let's not forget the epigenetic and environmental interactions. Stress,
- 2:25Speaker 1: Diet and pollution can significantly impact our health span. Epigenetic changes,
- 2:31Speaker 1: for instance, can alter gene expression in ways that affect aging,
- 2:36Speaker 1: much like the myth of Tithonus, where neglected youth leads
- 2:39Speaker 1: to a miserable existence.
- 2:40Speaker 2: Precisely. The narrative of Tithonus also underscores the need for
- 2:44Speaker 2: a balanced approach to aging. We can't just focus on
- 2:47Speaker 2: extending life. We need to ensure that our golden years
- 2:50Speaker 2: are truly golden. Now, moving on. How do public health
- 2:54Speaker 2: approaches play into this equation?
- 2:56Speaker 1: Public health initiatives are increasingly emphasizing the importance of healthspan.
- 3:01Speaker 1: Preventive measures and lifestyle modifications are being promoted as ways
- 3:05Speaker 1: to enhance quality of life during later years. Programs like
- 3:09Speaker 1: lifestyle coaching and public health campaigns aim to educate people
- 3:13Speaker 1: on healthier habits. This holistic approach is crucial.
- 3:18Speaker 2: Thomas. Definitely. And the narrative of Tithonus also hints at
- 3:22Speaker 2: the ethical and social implications of extending healthspan. For instance,
- 3:26Speaker 2: who will benefit most from these advancements? Will they exacerbate
- 3:30Speaker 2: existing disparities, or can we find a way to ensure
- 3:33Speaker 2: equitable access?
- 3:35Speaker 1: That's a critical point. The myth is a cautionary tale
- 3:38Speaker 1: about the unintended consequences of our quest for longevity. It's
- 3:42Speaker 1: a reminder that we need to consider both the quality
- 3:45Speaker 1: of life and the well-being of individuals as we pursue healthier,
- 3:50Speaker 1: longer lives. As we move forward, we need to balance
- 3:53Speaker 1: the desire for longevity with the need for vibrant healthspan.
- 3:57Speaker 1: We are starting to see some fascinating overlap here between
- 4:01Speaker 1: ancient myths and modern research. For instance, in the research today,
- 4:07Speaker 1: we are really delving into genomics. How does that play out? Thomas?
- 4:12Speaker 2: Precisely, Rachel. Genomics is the modern equivalent of these ancient stories.
- 4:17Speaker 2: By analyzing the genetic makeup of humans, scientists are finding
- 4:21Speaker 2: clues about aging and healthspan. Take telomeres, for example. These
- 4:25Speaker 2: terminal ends on chromosomes that shorten with each cell division.
- 4:29Speaker 2: Their length seems to correlate with our ability to maintain
- 4:33Speaker 2: health during aging.
- 4:34Speaker 1: Right. And that's the crucial nuance here. If we can
- 4:38Speaker 1: manage telomere length, we might be able to slow down
- 4:41Speaker 1: the cellular aging process. essentially buying more time for ourselves
- 4:45Speaker 1: and maintaining a healthier quality of life. It's a bit
- 4:49Speaker 1: like reversing the clock on each cell.
- 4:51Speaker 2: Exactly, which brings up an interesting contradiction. While telomere studies
- 4:56Speaker 2: are promising, we mustn't forget the metabolic and hormonal factors
- 5:00Speaker 2: at play. Insulin resistance, for instance, can really affect how
- 5:04Speaker 2: our bodies age. It can make us feel older than
- 5:07Speaker 2: we are, leading to premature aging and health problems.
- 5:10Speaker 1: That's wild when you look at the raw numbers. Studies
- 5:13Speaker 1: show that insulin resistance plays a significant role in a
- 5:16Speaker 1: range of age-related diseases. So, if we can manage insulin
- 5:21Speaker 1: levels better, it might not just keep us diabetic-free, but
- 5:25Speaker 1: also keep us feeling younger and healthier.
- 5:28Speaker 2: Indeed, and it's not just about metabolism. The interplay between
- 5:32Speaker 2: growth hormones and their role in longevity and health span
- 5:36Speaker 2: is another critical area of research. For instance … Human
- 5:39Speaker 2: growth hormone HE has been shown to have regenerative effects,
- 5:43Speaker 2: but too much of it or too little can really
- 5:46Speaker 2: influence how we age.
- 5:47Speaker 1: So, balancing these hormones becomes key. It's like a fine
- 5:51Speaker 1: line we have to walk to stay healthy. But let's
- 5:54Speaker 1: not forget about the environment and epigenetics. Stress, diet, pollution,
- 5:59Speaker 1: they all contribute to the aging process. How do we
- 6:02Speaker 1: factor those in?
- 6:03Speaker 2: Epigenetic changes are fascinating because they are influenced by both
- 6:08Speaker 2: our genes and our environment. They suggest that not only
- 6:12Speaker 2: does our DNA affect us, but what we do and
- 6:15Speaker 2: what we are exposed to can change how our genes
- 6:17Speaker 2: are expressed. This opens up possibilities for prevention and intervention.
- 6:22Speaker 1: And we are not just talking about old age here.
- 6:25Speaker 1: These are daily habits and choices that can impact how
- 6:28Speaker 1: we age. That's why public health policies are so important.
- 6:33Speaker 1: They might help us make better choices and ensure that
- 6:37Speaker 1: everyone has a chance to live a healthier, longer life.
- 6:40Speaker 2: Absolutely. Public health campaigns and policies need to be comprehensive,
- 6:45Speaker 2: hitting multiple fronts. They should aim to promote active lifestyles,
- 6:49Speaker 2: healthy diets, and manage exposure to environmental toxins. Otherwise, some
- 6:54Speaker 2: may benefit more than others deepening the health disparities we
- 6:57Speaker 2: see today.
- 6:58Speaker 1: So, it's all about a balanced approach, isn't it? We
- 7:02Speaker 1: need to address the biological aspects, but also consider the
- 7:06Speaker 1: social and environmental factors. It's a multifaceted challenge that requires
- 7:12Speaker 1: multifaceted solutions.
- 7:14Speaker 2: Precisely. And with ongoing research, hopefully we will see more
- 7:18Speaker 2: integrative approaches that combine all these different factors. It's not
- 7:22Speaker 2: just about extending life. It's about extending a healthy and
- 7:25Speaker 2: fulfilling life.
- 7:26Speaker 1: So, Thomas. How do we start bridging the gap between
- 7:30Speaker 1: extending life and preserving quality of life? It's clear that
- 7:34Speaker 1: the traditional focus on lifespan is incomplete without considering healthspan.
- 7:39Speaker 2: Absolutely, Rachel. The crux of the matter is balancing the
- 7:43Speaker 2: quantity and quality of life. Take, for instance, the example
- 7:47Speaker 2: of centenarians, many of whom are living with chronic diseases
- 7:51Speaker 2: and reduced functionality, questioning the value of those extra years
- 7:55Speaker 2: if they are not lived well. Right.
- 7:57Speaker 1: And that's the crucial nuance here. We need to look
- 8:00Speaker 1: at interventions not just through their impact on mortality, but
- 8:04Speaker 1: also on morbidity. For example, clinical trials around calorie restriction
- 8:10Speaker 1: and intermittent fasting show promising results in reducing age-related health issues.
- 8:15Speaker 2: That's a good point. But we also need to consider
- 8:19Speaker 2: the ethical and social implications of these interventions. Teresa risked
- 8:24Speaker 2: that they could exacerbate health disparities if they are only
- 8:27Speaker 2: accessible to the affluent.
- 8:29Speaker 1: Exactly. It's not just about development, it's about distribution. We
- 8:34Speaker 1: need policies and programs that ensure equity in access to
- 8:37Speaker 1: these healthspan-enhancing technologies.
- 8:40Speaker 2: Yes, and this brings us to the debate around risk
- 8:43Speaker 2: versus benefit. Some argue that we should focus on low-risk,
- 8:47Speaker 2: non-invasive interventions like lifestyle modifications. while others advocate for more
- 8:52Speaker 2: aggressive pharmacological and technological solutions.
- 8:56Speaker 1: It's a complex balance. Take the debate on senolytic drugs,
- 9:00Speaker 1: which target and eliminate senescent cells. They have shown potential
- 9:04Speaker 1: in animal studies, but have yet to prove their safety
- 9:07Speaker 1: and effectiveness in human populations.
- 9:09Speaker 2: True. But even as we move cautiously, we can learn
- 9:13Speaker 2: from public health approaches that prioritize preventive measures. Programs like
- 9:17Speaker 2: the American Geriatrics Society's focus on lifestyle and nutrition can
- 9:22Speaker 2: provide practical low-risk benefits.
- 9:24Speaker 1: Absolutely. Public health isn't just about reactive medicine. It's about
- 9:29Speaker 1: proactive measures that can significantly improve healthspan. The challenge is
- 9:34Speaker 1: scaling these initiatives globally.
- 9:36Speaker 2: Speaking of which, let's not forget the role of biotechnology
- 9:39Speaker 2: and technology companies in this landscape. They are developing tools
- 9:43Speaker 2: and apps that can empower individuals to manage their health
- 9:46Speaker 2: span more effectively.
- 9:48Speaker 1: Indeed, but we must also address the potential downsides. Aggressive
- 9:53Speaker 1: anti-aging therapies could lead to unintended consequences like immune system dysregulation.
- 9:50Speaker 1: That's key. We need an integrated approach that considers the
- 9:52Speaker 1: whole spectrum of biological, social, and technological factors. It's not
- 9:55Speaker 1: just about extending life but enhancing the quality of those
- 9:58Speaker 1: extended years. Exactly. The narrative of Tithonus still resonates today,
- 10:23Speaker 1: reminding us that longevity without healthspan is not a true victory.
- 10:27Speaker 1: We need to innovate while also ensuring that these advancements
- 10:30Speaker 1: are ethically sound and equitably distributed. As we look forward,
- 10:34Speaker 1: one of the critical research directions in healthspan is undoubtedly
- 10:38Speaker 1: the development of personalized medicine. By tailoring interventions based on
- 10:43Speaker 1: an individual's genetic makeup, we could potentially mitigate the negative
- 10:47Speaker 1: effects of aging at a more profound level. What do
- 10:51Speaker 1: you think, Thomas? How might this individualized approach change our strategies?
- 10:56Speaker 2: Great point, Alice. Personalized medicine could indeed transform public health approaches,
- 11:02Speaker 2: but it also raises some important questions about accessibility and equity.
- 11:07Speaker 2: For instance, how do we ensure that these advanced therapies
- 11:11Speaker 2: aren't just available to those who can afford them, potentially
- 11:14Speaker 2: widening the health disparity gap? It's a complex issue that
- 11:17Speaker 2: needs careful consideration from all angles.
- 11:20Speaker 1: Absolutely, and it's not just about the therapies themselves, but
- 11:23Speaker 1: also how they are delivered. For example, lifestyle modifications that
- 11:28Speaker 1: can be implemented through community programs might offer a more
- 11:31Speaker 1: equitable solution. The challenge, though, is how we balance these
- 11:35Speaker 1: personal and community-focused interventions without one overtaking the other.
- 11:39Speaker 2: Speaking of which, Alice, think about the role of technology
- 11:43Speaker 2: in all of this. Wearable devices and health apps have
- 11:46Speaker 2: already started to play a part, but they are predominantly consumer-driven.
- 11:50Speaker 2: How can we harness technology to not only engage individuals,
- 11:54Speaker 2: but also support public health initiatives on a larger scale?
- 11:57Speaker 2: It's an exciting area that could truly revolutionize how we
- 12:01Speaker 2: approach healthspan and longevity.
- 12:03Speaker 1: Indeed, technology definitely has a part to play. But it's
- 12:07Speaker 1: also crucial to ensure these tools are used ethically, ensuring
- 12:11Speaker 1: privacy and data protection are in place. the balance between
- 12:15Speaker 1: leveraging the potential of tech and maintaining ethical standards will
- 12:19Speaker 1: be key. I wonder, how do you think public health
- 12:22Speaker 1: authorities can best support this integration of technology into their
- 12:26Speaker 1: guidelines and policies?
- 12:28Speaker 2: Public health authorities need to establish clear frameworks and standards
- 12:32Speaker 2: for technologies that claim to enhance healthspan. They should also
- 12:37Speaker 2: collaborate with tech companies to ensure transparency and accountability. Additionally,
- 12:42Speaker 2: Policy should focus on promoting evidence-based interventions that benefit the
- 12:47Speaker 2: population as a whole, rather than just those who can
- 12:50Speaker 2: afford to use these new tools.
- 12:52Speaker 1: It's a multifaceted challenge, no doubt. As we move forward,
- 12:57Speaker 1: the key will be integrating these various approaches and ensuring
- 13:00Speaker 1: they all support the overarching goal of extending and enhancing healthspan.
- 13:05Speaker 1: What do you think are the biggest hurdles we need
- 13:07Speaker 1: to overcome to achieve this? Thomas.
- 13:10Speaker 2: Well, Alice, I'd say one of the biggest hurdles is
- 13:13Speaker 2: undoubtedly funding. Research and development in this area require significant investment,
- 13:20Speaker 2: but so do the public health campaigns and community initiatives.
- 13:24Speaker 2: Balancing these priorities could be tricky. Another hurdle might be
- 13:28Speaker 2: societal resistance to some of the more aggressive anti-aging interventions.
- 13:33Speaker 2: How do we navigate these sensitivities while still pursuing the
- 13:36Speaker 2: best course of action for public health?
- 13:38Speaker 1: Yes, those are definitely important points. Finally, let's not forget
- 13:43Speaker 1: the ethical implications. As we develop these new interventions, we
- 13:48Speaker 1: must constantly engage with ethicists to ensure our approaches are
- 13:52Speaker 1: responsible and equitable. It's a delicate balance, but one that's
- 13:56Speaker 1: essential for the future of healthspan and longevity. What else
- 14:00Speaker 1: do you see on the horizon that we should be
- 14:02Speaker 1: looking out for?
- 14:03Speaker 2: Absolutely, Alice. I think one area to keep an eye
- 14:07Speaker 2: on is the potential for new therapies that might address
- 14:09Speaker 2: the root causes of aging rather than just its symptoms.
- 14:13Speaker 2: Research in epigenetics and cellular reprogramming could lead to breakthroughs
- 14:16Speaker 2: that extend healthspan more profoundly. But again, it's crucial to
- 14:21Speaker 2: approach these with a cautious eye and comprehensive ethical considerations.
- 14:26Speaker 1: So, let's start with the basics. How do you define
- 14:30Speaker 1: healthspan and longevity in the context of aging?
- 14:33Speaker 2: Healthspan is the period of life spent in good health,
- 14:37Speaker 2: while longevity refers to the total number of years a
- 14:40Speaker 2: person lives. The key is the quality of those years.
- 14:43Speaker 1: That makes sense. But isn't the concept of Tithonus a
- 14:48Speaker 1: cautionary tale about the perils of focusing solely on longevity
- 14:52Speaker 1: without considering healthspan? Absolutely.
- 14:55Speaker 2: Tithonus' eternal torment due to his lack of youthful vitality
- 15:00Speaker 2: illustrates the importance of not just extending life but ensuring
- 15:04Speaker 2: its quality during that time.
- 15:06Speaker 1: Speaking of which, what are some of the key mechanisms
- 15:09Speaker 1: researchers are focusing on to improve healthspan and longevity?
- 15:14Speaker 2: Genetic and biological mechanisms like telomere length, autophagy, and cellular
- 15:20Speaker 2: senescence are hotspots. Plus, metabolic and hormonal factors, along with
- 15:25Speaker 2: epigenetic changes, are critical areas of study.
- 15:29Speaker 1: How do you see the public health approach evolving to
- 15:32Speaker 1: address healthspan and longevity?
- 15:34Speaker 2: Public health initiatives are shifting towards preventive measures and lifestyle modifications.
- 15:40Speaker 2: Programs like healthy lifestyle coaching and nutritional guidelines are increasingly common.
- 15:45Speaker 1: And what about the stakeholders involved in this narrative? Can
- 15:49Speaker 1: you talk about the roles of healthcare providers? Biotechnology firms
- 15:54Speaker 1: and the public?
- 15:54Speaker 2: Healthcare providers and researchers are crucial in developing interventions. Biotechnology
- 16:00Speaker 2: firms are introducing innovative therapies. Public health authorities are key
- 16:05Speaker 2: in shaping policies and guidelines that support healthy aging.
- 16:09Speaker 1: What are some of the most promising quantitative data points
- 16:12Speaker 1: or studies that inform our understanding of healthspan? and longevity.
- 16:17Speaker 2: Studies like the National Longitudinal Study of Aging and the
- 16:21Speaker 2: Health ABC Study provide detailed data. The Human Mortality Database
- 16:26Speaker 2: is also a goldmine for comparative life expectancy and health
- 16:30Speaker 2: span metrics.
- 16:31Speaker 1: And finally, what are some of the key contradictions, debate angles,
- 16:36Speaker 1: and perspectives in this discourse?
- 16:38Speaker 2: The main contradictions are between quality and quantity of life,
- 16:42Speaker 2: biological aging versus biological youth, and the ethical and social implications.
- 16:49Speaker 2: Perspectives vary on patient-centered versus system-centered approaches and biological versus
- 16:55Speaker 2: cultural factors.
- 16:56Speaker 1: Great points. What future outlook do you have for the
- 16:59Speaker 1: discourse on healthspan and longevity?
- 17:02Speaker 2: I see continued research leading to breakthroughs in healthspan enhancement.
- 17:06Speaker 2: Policies will evolve to support healthy aging, and consumer engagement
- 17:11Speaker 2: will drive demand for wellness products.
- 17:13Speaker 1: That brings us to the end of today's episode. Thank
- 17:16Speaker 1: you so much for spending part of your day with me.
- 17:18Speaker 1: If you found this episode's tips helpful and want to
- 17:21Speaker 1: make sure you don't miss the next conversation, please take
- 17:24Speaker 1: a quick second to hit that subscribe or follow button
- 17:27Speaker 1: on whatever platform you are listening on. It's a completely
- 17:30Speaker 1: free way to support the show and helps more people
- 17:33Speaker 1: find us. This podcast is independently produced, so if you
- 17:37Speaker 1: are ever in a position where you would like to
- 17:39Speaker 1: help keep it running, we do accept small donations. You
- 17:43Speaker 1: can find a link right in the episode description below
- 17:46Speaker 1: to buy us a coffee or contribute what you can.
- 17:49Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 17:54Speaker 1: and we will talk again soon.